The healthcare industry, and explicitly the pharmacovigilance business, perceives the need to help the expanding measure of information got from individual case safety reports (ICSRs). To adapt to this expansion, more healthcare and qualified experts are required to catch and assess the information. To address the advancing scene, it will be important to hold onto assistive advancements, for example, artificial intelligence (AI) at scale. artificial intelligence in the field of pharmacovigilance will conceivably bring about the change of the drug safety (DS) expert's everyday work life and their vocation advancement.